Published studies have revealed that VASP is upregulated in cancers such as breast cancer 34, glioma 35 and HCC 36 and promotes the biological function of cancer cells by activating PI3K/AKT pathway 19, 37. This evidence concerns the gene AKT1 and hepatocellular carcinoma.